Peroral gene therapy of diabetes and obesity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 7, 2003
Grant Date -
N/A
app pub date -
Feb 22, 2000
filing date -
Feb 19, 1999
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention provide methods and compositions for targeting endocrine cells capable of converting an immature expressed protein into a mature protein, and secreting the expressed protein into the systemic circulation. In particular, the invention features methods and compositions for treating disorders, such as diabetes by orally administering a vector expressing insulin to target cells which can subsequently secrete the expressed insulin into the blood circulation.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully